Restricted accessResearch articleFirst published online 2026-2
Identification and characterization of unknown photo-oxidation degradation components of ganciclovir by high-performance liquid chromatography and quadrupole time-of-flight mass spectrometry
Ganciclovir (GCV) is an antiviral drug used to treat cytomegalovirus infections associated with AIDS. The study of the GCV drug substance under photo-oxidation stress conditions identified five impurities. This study aims to interpret the chemical structures of the photo-oxidation products using quadrupole time-of-flight (Q-TOF) mass spectrometry. An optimized chromatographic technique employing reverse-phase high-performance liquid chromatography with photodiode array detection was used to identify the degradation products of GCV. This technique utilized an Endurus Phenyl-hexyl HP column with an eluent mixture of acetonitrile, methanol, and 1 M ammonium formate (pH 3.2). GCV's photo-oxidation products were effectively separated, achieving a resolution higher than 2.0. The Q-TOF mass spectrometry analysis characterized the five degradation products, which included 8-Oxo GCV, secondary degradation of 8-Oxo GCV, guanine, and one dehydrogenated compound. These new impurities require special attention because the drug's potency and impurity levels significantly influence the quality, safety, and effectiveness of pharmaceutical products.
MeloSRDOHomem-De-MelloMSilveiraD, et al.Advice on degradation products in pharmaceuticals: a toxicological evaluation. PDA J Pharm Sci Technol2014; 68: 221–238.
Office of Pharmaceutical Quality. Establishing Impurity Acceptance Criteria as Part of Specifications for NDAs, ANDAs, and BLAs Based on Clinical Relevance. Manual of Policies and Procedures; MAPP 5017.2 Rev. 1. 2020, https://www.fda.gov/media/124859/download. (accessed 29 August 2025).
8.
UmmitiKVakkalaSPanugantiV, et al.Isolation, identification, and characterization of 17-OXO dexamethasone, an oxidative degradation impurity of dexamethasone using flash chromatography and NMR/HRMS/IR. J Liq Chromatogr Relat Technol2013; 37: 2403–2419.
9.
BapatuHRMaramRKMurthyRS. Robust and rugged stability-indicating HPLC method for the determination of plerixafor and its related impurities in drug substances. J Chromatogr Sci2015; 53: 1432–1442.
10.
VangaNRKVRUmmitiK, et al.Development of a stability-indicating purity method for ubrogepant through stress degradation analysis, extraction, and characterization of unidentified degradation products using flash chromatography, NMR, IR, and LC-MS. J AOAC Int2024; 107: 761–773.
11.
GodiNRDoddaSVangaNR, et al.Identification and characterization of unknown oxidation degradation products of Rimegepant by HPLC and triple quadrupole mass spectrometry. Eur J Mass Spectrom2025; 31: 38–50.
12.
UmmitiKKumarJS. Establishment of validated stability indicating purity method based on the stress degradation behavior of gonadotropin-releasing hormone antagonist (ganirelix) in an injectable formulation using HPLC and LC-MS-QTOF. Eur J Mass Spectrom2021; 27: 126–140.
13.
GanthiHKRPRRParkYJ, et al.Stability indicating HPLC method for quantification of solifenacin succinate & Tamsulosin hydrochloride along with its impurities in tablet dosage form. Am J Anal Chem2016; 07: 840–862.
14.
KogawaACSalgadoHRN. Impurities and forced degradation studies: a review. Curr Pharm Anal2015; 12: 18–24.
15.
MukkapatiVMaddalaVKSBapatuHR, et al.Identification and structural elucidation of a potential citric acid and caprolactam adduct impurity in aminocaproic acid injection using preparative chromatography, LC–MS, and NMR. Separation Sci Plus2025; 8: e70031.
16.
UmmitiKVangaNR. Identification, isolation, structure characterization, and chromatographic separation of a new highly analogous impurity of the ubrogepant. Curr Anal Chem2025; 22: 126–145.
17.
VangaNRKesamsettyVRUmmitiK, et al.Development of a reliable purity method for ataluren in a sachet formulation through the analysis of its stress degradation behavior using HPLC, LC-MS, and 2D-NMR. Separation Sci Plus2025; 8: e70118.
RameshPJBasavaiahKVinayKB, et al.Development and validation of RP-HPLC method for the determination of Ganciclovir in bulk drug and in formulations. ISRN Chromatography2012; 2012: 1–8.
LeanpolchareanchaiJTangteerakoonPSupapsophonP, et al.Extemporaneous preparation of 20 mg/mL Ganciclovir in artificial tears in comparison with Sterile water for ophthalmic administration: formulation and stability study. Pharmaceutics2023; 15: 208.
KinoKHirao-SuzukiMMorikawaM, et al.Generation, repair and replication of guanine oxidation products. Genes and Environ2017; 39: 21.
24.
FlemingAMBurrowsCJ. Chemistry of ROS-mediated oxidation to the guanine base in DNA and its biological consequences. Int J Radiat Biol2021; 98: 452–460.
25.
PowellMFMagillAChuN, et al.Chemical and enzymatic degradation of ganciclovir prodrugs: enhanced stability of the diadamantoate prodrug under acid conditions. Pharm Res1991; 08: 1418–1423.
